Loading people...
Asha Nayak is the Vice President and Global Head of Consumer Health Investments at Johnson & Johnson Innovation in San Francisco. Before joining the corporate venture arm in 2020, she served as Chief Medical Officer at Intel Corporation and held clinical leadership positions as a corporate officer at Medtronic. Her venture capital and governance experience includes working as a Vice President at New Leaf Venture Partners and serving as an Independent Director at SAGE Therapeutics. She earned an MD and a PhD in Neuroscience from the University of Colorado Anschutz, completed a Biodesign fellowship at Stanford University, and practiced as an ER Physician. Currently serving as a Director at Pivot Health Technologies and a Stanford Biodesign board member since 2021, Nayak focuses on strategic investments across consumer health, medical devices, and digital healthcare technology.
Asha Nayak is a distinguished investor at Johnson & Johnson Innovation, a global leader in fostering healthcare breakthroughs. In her crucial role, Asha Nayak is instrumental in scouting, evaluating, and investing in promising startups and emerging companies that align with Johnson & Johnson's mission to transform human health. Her work at Johnson & Johnson Innovation involves building strategic partnerships and providing capital to accelerate the development of innovative solutions.
Johnson & Johnson Innovation, with Asha Nayak as a key team member, actively seeks out pioneering advancements across various sectors of healthcare. Asha's investment focus areas typically encompass pharmaceuticals, medical devices, digital health, consumer health, and biotechnology. She looks for companies developing novel therapeutics, diagnostics, surgical tools, and digital platforms that have the potential to significantly impact patient care and improve health outcomes globally. Her expertise lies in identifying technologies and business models that can complement and expand Johnson & Johnson's existing portfolio, driving both scientific progress and commercial success.
While specific details of Asha Nayak's career background are not publicly detailed, investors at Johnson & Johnson Innovation typically possess a robust blend of scientific acumen, business development expertise, and venture capital experience. It is common for professionals in her position to have backgrounds in life sciences, medicine, or engineering, often complemented by advanced degrees such as an MBA or PhD. This multidisciplinary foundation enables them to thoroughly assess the scientific validity, market potential, and strategic fit of potential investments. Their careers often involve prior roles in research and development, corporate strategy, or venture capital firms specializing in healthcare.
Through Johnson & Johnson Innovation, Asha Nayak contributes to a legacy of supporting groundbreaking companies. While individual notable investments by Asha Nayak are not typically publicized, the organization as a whole has a strong track record of backing companies that go on to achieve significant milestones in drug discovery, medical technology, and consumer health innovation. Asha Nayak's efforts are vital in ensuring that Johnson & Johnson remains at the forefront of healthcare innovation, bringing transformative solutions from concept to reality for patients worldwide.
Asha Nayak is an investor at Johnson & Johnson Innovation, a division dedicated to identifying and supporting groundbreaking healthcare companies and technologies.
Asha Nayak invests in a broad range of healthcare innovations, including pharmaceuticals, medical devices, digital health solutions, consumer health products, and biotechnology advancements, through Johnson & Johnson Innovation.
Asha Nayak works as an investor at Johnson & Johnson Innovation, the strategic venture arm of Johnson & Johnson, focused on external innovation and partnerships.
